Vanta-Bioscience (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces changes to the Long Term ASM Framework effective March 06, 2026, including 3 new securities shortlisted, 1 security moved to … | |||||||||||||||
BSE announces changes to the Long Term ASM Framework effective March 06, 2026, including 3 new securities shortlisted, 1 security moved to higher stage, and 2 securities removed from the framework.
| |||||||||||||||
BSE announces changes to the Long Term ASM Framework effective March 06, 2026, including 3 new securities shortlisted, 1 security moved to … | |||||||||||||||
BSE announces changes to the Long Term ASM Framework effective March 06, 2026, including 3 new securities shortlisted, 1 security moved to higher stage, and 2 securities moved out of LT-ASM.
| |||||||||||||||
BSE announces 6 securities newly shortlisted under the Short Term 5/15/30 Days ASM Framework and 10 securities moving out, effective … | |||||||||||||||
BSE announces 6 securities newly shortlisted under the Short Term 5/15/30 Days ASM Framework and 10 securities moving out, effective February 26, 2026.
| |||||||||||||||